You were compliant. Patient. Diligent. You did the thing that was asked of you, in the order it was asked, for as long as it was asked. And the protocol that was supposed to work simply did not.
At which point something subtle shifted. The system stopped questioning the protocol and started questioning the patient.
The flowchart is too small for your biology
Here is the reframe that makes your history legible: you are not the problem. The flowchart is too small for your biology.
A standardized protocol is a decision tree. It takes a presenting complaint, applies a sequence of steps in a defined order, and produces a recommendation. That structure has genuine virtues — it is consistent, it is teachable, it is auditable, and it prevents a great deal of arbitrary variation in care.
But a decision tree encodes an assumption about what is driving the condition it treats. It has to. Every branch reflects a model of the underlying problem, and the steps that follow only make sense if that model applies to the person in front of it.
Pain is heterogeneous
That assumption is where the trouble starts, because pain is not one thing wearing different labels.
Pain is heterogeneous. For one person it is driven primarily by metabolic inflammation. For another, by a sensitized nervous system. For another, by the dietary signal. Three patients can present with the same complaint, in the same joint, with similar imaging, and be experiencing conditions with fundamentally different engines.
A single standardized protocol can only target one of those drivers. It cannot target all of them simultaneously, because a decision tree by construction commits to a model. So the protocol works — genuinely and reliably — for the subset of patients whose dominant driver happens to be the one it assumes.
And if your dominant driver is not the one it assumes, you do not resolve. Not because you executed poorly. Not because your case is unusually severe. Because the intervention was aimed at a mechanism that was not the one operating in you.
Mismatch, not failure
The distinction between mismatch and failure is worth holding onto, because it changes what the next step should be.
A failure invites more of the same, applied harder. If the protocol was right and the result was poor, the logical response is another round, better adherence, closer supervision. That is how patients end up cycling through repeat courses of the same approach with diminishing enthusiasm on both sides.
A mismatch invites something different: identifying which driver is actually dominant, and selecting the intervention that targets it. That is not a harder version of the same effort. It is a different question entirely.
This is also why the interpretation matters emotionally, not only clinically. Being told a protocol failed leaves an implication hanging in the air. Understanding it as a mismatch removes the implication and replaces it with a specific, answerable question.
Why the system defaults to suspecting the patient
None of this is an indictment of any clinician. It is a description of what happens at the edges of a standardized system.
When a protocol has been applied correctly and the outcome is poor, the framework has a limited set of variables it can question. The protocol is validated. The delivery was documented. What remains is the patient — adherence, effort, expectations, psychology. So attention drifts there, not out of unkindness, but because it is the only unexamined variable the model contains.
The variable the model does not contain is whether the right driver was ever identified. That question requires stepping outside the flowchart, and the flowchart has no step for stepping outside itself.
What a personalized approach does differently
The alternative is to determine your dominant driver before selecting the intervention, rather than applying a standard sequence and inferring from the result.
That means measuring rather than assuming. If metabolic inflammation is the engine in your case, that is identifiable. If a sensitized nervous system is doing the work, that is a different finding with different implications. If the dietary signal is central, that points somewhere else again. The point is that these are distinguishable — but only if someone looks, and looking is not a step the standard pathway includes.
A personalized, measured approach finds what the flowchart cannot, because it is not committed in advance to a single model of your problem.
If you have completed a protocol faithfully and not resolved, the next reasonable step is not a third attempt at it. It is an evaluation designed to establish which driver is actually operating in you.
Frequently asked questions
Should I stop the protocol I am currently following?
No. Do not start, stop, or change any treatment without consulting your physician. If this article describes your experience, bring it to the physician managing your care, or seek a formal evaluation — and continue what has been prescribed unless your physician advises otherwise.
Does this mean standardized protocols are bad medicine?
No. Standardization prevents arbitrary variation and works reliably for the patients whose dominant driver matches the one the protocol assumes. The limitation is inherent rather than a defect: a decision tree must commit to a model of the problem, so it cannot cover every mechanism at once.
How would anyone determine which driver is dominant in my case?
Through measurement rather than inference. Metabolic inflammation, a sensitized nervous system, and the dietary signal are distinguishable, but only if they are specifically assessed — which is a step a standard pathway does not contain. Individual results vary, and what applies to you is established by evaluation.
Could more than one driver be involved at the same time?
Pain is heterogeneous across patients, and the practical question is which driver is dominant for you — because that is what determines whether a given intervention has a mechanism to act on. This is precisely the kind of question that requires an individual assessment rather than an assumption.
Key takeaways
- A protocol that did not resolve your pain is a mismatch, not a personal failure.
- Pain is heterogeneous: metabolic inflammation, a sensitized nervous system, and the dietary signal are different engines.
- A standardized protocol can only target one driver, so it works for the subset whose driver it assumes.
- When outcomes are poor, a standardized system tends to question the patient — the only variable it has left.
- Identifying your dominant driver through measurement is what a personalized approach adds.
Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.
This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician.
Find out what is actually driving your pain
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, imaging, and metabolic data, and a written terrain roadmap. Evaluation is contingent upon review of your data.
Questions? Call (314) 295-3000 or text (314) 886-5902.
